236
Views
3
CrossRef citations to date
0
Altmetric
Original

SEMIFLUORINATED SYMMETRICAL DIETHERS FOR INTRAOCULAR USE: SYNTHESIS, CHARACTERIZATION, AND IN VITRO BIOCOMPATIBILITY

, , , &
Pages 71-83 | Published online: 11 Jul 2009
 

Abstract

Semifluorinated symmetrical diethers were synthesized using the William ether synthesis. These diethers should have similar properties to perfluorocarbons as are chemical inertness and high oxygen solubility, but in contrast a considerably lower density. With their lower density the damaging of the choroidal tissue of the eye observed with perfluorocarbons should be avoided. The synthesized diethers are inert compounds being stable against nucleophiles, oxidiziers and strong bases. Their density is in the range of 1.1–1.2 g/cm3. Besides the physical and chemical tests we conducted several in vitro biocompatibility tests. The tests comprised induction of hemolysis, the generation of C3a complement, the influence on the production of interleukin1β, the influence on cell proliferation of a Raji and a Hela cell line (3H-Thymidine uptake) and finally the direct cytotoxic effect on these cell lines. All tested symmetrical diethers were positive in one or more tests and can be expected to be incompatible in vivo. Especially the “short” semifluorinated diethers [(CF3CH2O)2(CH2)3–6] showed a nearly total inhibition of cell proliferation or interleukin1β release. Further variation of the compounds will be necessary to generate better biocompatible derivates.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.